e-learning
resources
Virtual 2020
Pre-Congress Content
News on diagnosis and therapy of idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Concurrent validity among three field tests and the cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis.
D. Dos Reis Estrella (Belo Horizonte (MG), Brazil), H. Pereira (Belo Horizonte (MG), Brazil), E. Viana Mancuzo (Belo Horizonte (MG), Brazil), G. Samora (Belo Horizonte (MG), Brazil), B. Silveira (Belo Horizonte (MG), Brazil), A. Pataro (Belo Horizonte (MG), Brazil), V. Parreira (Belo Horizonte (MG), Brazil)
Source:
Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Session:
News on diagnosis and therapy of idiopathic pulmonary fibrosis
Session type:
E-poster session
Number:
790
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Dos Reis Estrella (Belo Horizonte (MG), Brazil), H. Pereira (Belo Horizonte (MG), Brazil), E. Viana Mancuzo (Belo Horizonte (MG), Brazil), G. Samora (Belo Horizonte (MG), Brazil), B. Silveira (Belo Horizonte (MG), Brazil), A. Pataro (Belo Horizonte (MG), Brazil), V. Parreira (Belo Horizonte (MG), Brazil). Concurrent validity among three field tests and the cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis.. 790
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Year: 2007
Pulmonary function and cardiopulmonary exercise tests in patients with bronchiectasis
Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases
Year: 2010
Endurance time is the most sensitive exercise measurement for evaluating pulmonary rehabilitation efficacy in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation
Year: 2012
Cardiopulmonary exercise testing in patients with severe pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 489s
Year: 2001
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing
Year: 2011
Characteristic of four exercise tests in patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients
Year: 2018
Physiological responses to cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 66s
Year: 2006
Relationship of cardiopulmonary exercise testing (CPET) and lung function in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2007; 30: Suppl. 51, 120s
Year: 2007
Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients
Source: Eur Respir J, 57 (1) 2004265; 10.1183/13993003.04265-2020
Year: 2021
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012
Ventilatory efficiency and exercise capacity during exercise in the patients with idiopathic pulmonary fibros
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014
Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing
Source: Eur Respir Rev 2017; 26: 160099
Year: 2017
Comparison of three walking tests to cardiopulmonary exercise tests in the assessment of exercise tolerance in individuals with pulmonary arterial hypertension
Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients
Year: 2016
Maximal cardiopulmonary exercise testing in children with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Cardiopulmonary exercise testing in the evaluation of the indication and efficacy of pulmonary rehabilitation
Source: ERS Course 2020 - Pulmonary rehabilitation
Year: 2020
Evaluation of exercise capacity and mechanisms of limitation during cardiopulmonary exercise testing (CPET) in patients with chronic hypersensitivity pneumonitis
Source: International Congress 2018 – New methods and concepts in exercise testing
Year: 2018
Cardiopulmonary exercise test to predict pulmonary rehabilitation outcome in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept